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worry (p = 0.281) and vaccination intentions (p = 0.467) 
did not significantly interact with country status.
Our results indicate that the choice of disease labels for 
public communications about outbreaks cannot be made by 
personal preference. In this study, an animal reservoir la-
bel evoked weaker responses from participants than other 
labels. Although these results could be specific to the ani-
mal we chose, using an animal reservoir label may produce 
greater misconceptions (e.g., exposure to the animal neces-
sary for transmission) that undermine suspicions of risk. 
Further research is needed to determine whether this effect 
is context-specific or generalizes to other animal reservoir 
labels for infectious diseases and whether our findings rep-
licate in a nonhypothetical context.
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Figure. Regression coefficients for the effect of influenza labels on 
worry for infection and intentions for vaccination. Label conditions 
were dummy coded to estimate the effects of “H11N3 influenza” 
(X1) and “Yarraman flu” (X2) labels compared with the “horse flu” 
label. The effect of influenza labels on vaccination intentions, 
controlling for worry, is in parentheses. **p<0.01; ***p<0.001.
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We evaluated the risk for the Spanish Olympic Team acquir-
ing Zika virus in Rio de Janeiro, Brazil, during 2016. We re-
cruited 117 team members, and all tested negative for Zika 
virus. Lack of cases in this cohort supports the minimum risk 
estimates made before the Games.
The current Zika virus epidemic became a major concern for national Olympic delegations before they traveled 
to Rio de Janeiro, Brazil, during summer 2016. Fear about 
individual consequences of the infection, such as congeni-
tal or neurologic disorders, were common among athletes 
and other participants of the Olympic Games and led some 
persons not to attend the Games for these reasons. The pos-
sibility of the Olympics contributing to a global spread of 
the Zika virus epidemic also was a concern, initially raised 
by ≈100 academic researchers, expressed in an open let-
ter addressed to the World Health Organization (WHO) in 
May 2016 (1,2).
The risk for Zika during the Rio de Janeiro Olympic 
Games was estimated to be very low in different models 
published in medical journals (9 × 10−6 to 3 × 10−5) (3–6). 
After considering these figures, WHO advised that the 
Games should not substantially affect the epidemic (7).
To evaluate the risk for the Spanish Olympic Team ac-
quiring Zika virus, our research group from 6 hospitals in 
Spain invited members of the Spanish delegation to partici-
pate in a serologic study of Zika virus 20 and 30 days after 
returning from Rio de Janeiro. The study was conducted 
in 6 different recruiting Tropical Medicine Units in cities 
in Spain (Barcelona, Madrid, Sevilla, San Sebastian, Las 
Palmas de Gran Canaria, and Almeria).
Athletes and other participants were invited to partici-
pate in the study through the Spanish Olympic Commit-
tee. A total of 117 Olympics participants accepted and were 
included in the study during September and October 2016. 
After providing oral and written information, study partici-
pants signed an informed consent form, and demographic 
and health data were recorded in a medical questionnaire. 
A total of 10 mL of blood was drawn from each participant, 
and serologic tests for Zika virus (immunofluorescence 
antibody assay; EUROIMMUN, Luebeck, Germany), den-
gue virus (ELISA; Panbio, Kyonggi-do, Republic of Ko-
rea), and chikungunya virus (immunofluorescence assay; 
EUROIMMUN) were conducted at the Instituto de Salud 
Carlos III (Spanish National Reference Laboratory, Ma-
drid, Spain). For all samples initially testing positive for 
Zika virus, we conducted microneutralization testing.
Twenty-one participants had >1 signs or symptoms 
while in Brazil: 18% rash, 23% fever (temperature >38°C), 
14% itching, 9% of conjunctival hyperemia, 9% arthralgia, 
14% myalgia, 40% malaise, 9% lymphadenopathy, 32% 
headache, and 19% gastrointestinal symptoms. Ninety-nine 
percent of participants received Zika virus counseling be-
fore they traveled to Rio de Janeiro, including the advice of 
having protected sex during and after the Games (Table).
For 4 persons, test results for Zika virus IgG was 
positive; IgM and neutralization testing yielded negative 
results. The 4 Zika virus IgG–positive participants had re-
ceived previous yellow fever vaccination and were asymp-
tomatic. One sample showed Zika virus IgM in the absence 
of specific IgG; the results were confirmed in a follow-up 
sample. Thus, the sample was classified as false positive.
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Table. Demographic and travel-related characteristics of 117 
Spanish athletes who attended the Olympic Games, Rio de 




 M 76 (65.0) 
 F 41 (35.0) 
Age, y, median  SD 35.54  9.46 
Athletes  
 All athletes 53 (45.3) 
  Outdoor athletes 35 (66.0) 
Spanish nationality 112 (95.7) 
Chronic disease 6 (5.1) 
 Immunosuppression 0 
Current pregnancy, own or partner’s 9 (7.7)† 
Intention to conceive within the following 6 mo 29 (24.8) 
 Sex  
  M  22 (75.9) 
  F 7 (24.1) 
Vaccination and travel advice  
 Vaccine  
  Yellow fever 23 (19.6) 
  Japanese encephalitis 0 
  Tickborne encephalitis 0 
 Attendance at a travel clinic 115 (98.3) 
  Zika advice included 116 (99.2) 
>1 Visit to a tropical country 74 (63.3) 
Previous diagnosis of dengue 0 
During the trip 
 
 Length of stay, d, median  SD 21.35  9.05 
 Places visited 
 
  Rio de Janeiro 103 (88) 
  Rio de Janeiro, Deodoro, and Barra 7 (6.0) 
  Rio de Janeiro and Ilha Grande 4 (3.4) 
  Rio de Janeiro and Paraty 1 (0.85) 
  Rio de Janeiro and French Polynesia 1 (0.85) 
Use of bed nets or air conditioners 61 (52.6) 
Use of repellent 111 (94.9) 
Risky sexual behavior 2 (1.7) 
Recall >1 mosquito bite during stay 56 (47.9) 
*All values are no. (%) unless otherwise indicated. 
†Male participants’ partners who were pregnant before the Games. 
 
Study participants were advised to wait to conceive in 
accordance with WHO specifications: 6 months for men, 
2 months for women. Participants with pregnant partners 
were advised to use condoms during the entire pregnancy.
A lack of Zika cases in this cohort supports the risk cal-
culations made before the Games and the WHO statement 
that there were no Zika cases associated with the Olympic 
Games (8). Although 48% of participants in our study re-
called at least 1 mosquito bite during the stay, the overall 
absence of cases in the Rio de Janeiro population during 
July and August 2016 (9,10) is believed to be due to the 
vector-control efforts by Brazilian authorities before the 
Games and to the winter weather, leading to a low presence 
of adult mosquitoes and mosquito bites (5,6).
This work was supported by La Caixa Foundation and the  
Spanish Olympic Committee. The laboratory work was  
supported by RICET (Network Biomedical Research on Tropical 
Diseases), RD16CIII/003/003.
Dr. Rodriguez-Valero is an internal medicine specialist working 
in travel medicine since 2015. Her research interests include 
new technologies in travel medicine, outbreaks, and emerging 
infectious diseases.
References
  1. World Health Organization. Zika virus and the Olympic and  
Paralympic Games Rio 2016 [cited 2016 Dec 26].  
http://www.who.int/mediacentre/news/statements/2016/ 
zika-olympics/en/
  2. Attaran A, Caplan A, Gaffney C, Igel L. Open letter to Dr. Margaret 
Chan, Director-General, WHO (copied to the International Olympic 
Committee) [cited 2017 June 9]. http://www.gannett-cdn.com/
usatoday/editorial/sports/olympics/zika-olympics-open-letter.pdf 
  3. Massad E, Tan S-H, Khan K, Wilder-Smith A. Estimated Zika virus 
importations to Europe by travellers from Brazil. Glob Health  
Action. 2016;9:31669. http://dx.doi.org/10.3402/gha.v9.31669  
  4. Zumla A, McCloskey B, Bin Saeed AA, Dar O, Al Otabi B,  
Perlmann S, et al. What is the experience from previous mass  
gathering events? Lessons for Zika virus and the Olympics 2016. 
Int J Infect Dis. 2016;47:1–4. http://dx.doi.org/10.1016/ 
j.ijid.2016.06.010
  5. Codeço C, Villela D, Gomes MF, Bastos L, Cruz O, Struchiner C, 
et al. Zika is not a reason for missing the Olympic Games in Rio 
de Janeiro: response to the open letter of Dr Attaran and colleagues 
to Dr Margaret Chan, Director-General, WHO, on the Zika threat 
to the Olympic and Paralympic Games. Mem Inst Oswaldo Cruz. 
2016;111:414–5. http://dx.doi.org/10.1590/0074-02760160003
  6. Grills A, Morrison S, Nelson B, Miniota J, Watts A, Cetron MS. 
Projected Zika virus importation and subsequent ongoing  
transmission after travel to the 2016 Olympic and Paralympic 
Games—country-specific assessment, July 2016. MMWR Morb 
Mortal Wkly Rep. 2016;65:711–5. http://dx.doi.org/10.15585/
mmwr.mm6528e1
  7. World Health Organization. Public health advice regarding the 
Olympics and Zika virus [cited 2016 Dec 26]. http://www.who.int/
mediacentre/news/releases/2016/zika-health-advice-olympics/en/
  8. World Health Organization. Fourth meeting of the Emergency 
Committee under the International Health Regulations (2005) 
regarding microcephaly, other neurological disorders and Zika 
virus [cited 2016 Dec 26]. http://www.who.int/mediacentre/news/
statements/2016/zika-fourth-ec/en/
  9. Ministerio da Saude. Secretaria de Vigilància em Saúde.  
Boletim Epidemiológico. Vol 47-no33.; Brasilia 2016 [cited 2017 
June 11]. http://portalarquivos.saude.gov.br/images/pdf/2016/
setembro/16/2016-028---Dengue-SE32.pdf 
10. Ministerio da Saude. Secretaria de Vigilància em Saúde. Boletim 
Epidemiológico. Vol 47-no34.; Brasilia 2016 [cited 2017 June 11]. 
http://portalsaude.saude.gov.br/images/pdf/2016/outubro/18/ 
2016-029-Dengue-publicacao-n-34.pdf
Address for correspondence: Natalia Rodriguez-Valero and  
Jose Muñoz, Department of Tropical Medicine and International  
Health, Hospital Clinic Barcelona. ISGlobal, Barcelona Centre for 
International Health Research (CRESIB), Hospital Clínic-Universitat de 
Barcelona C/Rosselló 132 2°2ª, 08036, Barcelona, Spain; email:  
natalia.rodriguez@isglobal.org and jose.munoz@isglobal.org
Candidatus Dirofilaria  
hongkongensis as Causative 
Agent of Human Ocular  
Filariosis after Travel to India
Stefan Winkler, Andreas Pollreisz,  
Michael Georgopoulos, Zsuzsanna Bagò-Horvath, 
Herbert Auer, Kelvin Kai-Wang To,  
Jürgen Krücken, Sven Poppert, Julia Walochnik
Author affiliations: Medical University of Vienna, Vienna, Austria 
(S. Winkler, A. Pollreisz, M. Georgopoulos, Z. Bagò-Horvath,  
H. Auer, J. Walochnik); University of Hong Kong, Pokfulam, Hong 
Kong, China (K.K-.W. To); Freie Universität Berlin, Germany  
(J. Krücken); Bernhard Nocht Institute for Tropical Medicine,  
Hamburg, Germany (S. Poppert); Regio Klinikum, Wedel,  
Germany (S. Poppert)
DOI: https://doi.org/10.3201/eid2308.170423
We report a human case of ocular Dirofilaria infection in 
a traveler returning to Austria from India. Analysis of mi-
tochondrial sequences identified the worm as Candidatus 
Dirofilaria hongkongensis, a close relative of Dirofilaria re-
pens, which was only recently described in Hong Kong and 
proposed as a new species.
Dirofilariosis, caused by Dirofilaria repens or D. immitis nematodes, is a zoonotic filarial infection transmitted 
through the bite of various mosquitoes. The most frequent 
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